Trial Details
RECRUITINGBasic Information
| Clinical ID | c536 |
|---|---|
| Identifier | NCT06456593 |
| Trial Title | Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Moderately to Severely Active Crohn Disease |
| Interventions | DRUG: Obefazimod|OTHER: Placebo |
Participant Information
| Sponsor | Abivax S.A. |
|---|---|
| City | Fairhope |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2024-10-30 |
|---|---|
| Primary Completion Date | 2026-12 |
| Completion Date | 2028-04 |